European Patent Office

T 0164/83 (Antihistamines) vom 17.07.1986

Europäischer Rechtsprechungsidentifikator
ECLI:EP:BA:1986:T016483.19860717
Datum der Entscheidung
17. Juli 1986
Aktenzeichen
T 0164/83
Antrag auf Überprüfung von
-
Anmeldenummer
80104372.0
IPC-Klasse
C07D 473/08
Verfahrenssprache
Englisch
Verteilung
Im Amtsblatt des EPA veröffentlicht (A)
Amtsblattfassungen
Weitere Entscheidungen für diese Akte
-
Zusammenfassungen für diese Entscheidung
-
Bezeichnung der Anmeldung
-
Name des Antragstellers
EISAI
Name des Einsprechenden
-
Kammer
3.3.02
Leitsatz

1. Technical progress shown in comparison with marketed products as an alleged support for inventive step cannot be a substitute for the demonstration of inventive step with regard to the relevant closest state of the art. (Following T 181/82 "Spiro-Compounds/Ciba- Geigy", OJ 9/1984,401).

2. The possibility of a prohibition of experiments with animals in one Contracting State of the EPC is not a sufficient reason for declining the submission of test results in comparison with the closest state of the art if the inventive step can only be demonstrated in this manner.

Schlagwörter
Inventive step
Quantitative improvement
Technical progress
Comparative tests
Novelty of selection
Experiments with animals
Orientierungssatz
-
Zitierte Akten
-

ORDER

For these reasons, it is decided that:

1. The impugned decision is set aside.

2. The application is remitted to the Examining Division for further prosecution. The applicant has to submit test results comparing the claimed properties (cf. Claim 7) of the compound described on page 3, lines 19 and 20 of the application with those of Example 38.2 of GB-A-1 889 287 (page 10, lines 24-26) by 31 January 1987. Decision of Technical Board of Appeal 3.3.2 dated 25 September 1986